CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation

He,Haitao; Chai,Jianshen; Zhang,Shengfu; Ding,Linlin; Yan,Peng; Du,Wenjun; Yang,Zhenzhou

doi:10.3892/mmr.2016.5023

CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation

Authors:
- Haitao He
- Jianshen Chai
- Shengfu Zhang
- Linlin Ding
- Peng Yan
- Wenjun Du
- Zhenzhou Yang
View Affiliations

Affiliations: Department of Maxillofacial and Head and Neck Surgery, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, P.R. China, Department of Oncology, Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, P.R. China
Published online on: March 21, 2016 https://doi.org/10.3892/mmr.2016.5023
Pages: 3977-3984

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Calcitonin-gene-related peptide (CGRP) is a neuropeptide, which is widely distributed throughout the central and peripheral nervous systems. Numerous mechanisms underlying the action of CGRP in osteoblast-associated cells have been suggested for bone growth and metabolism. The present study was designed to closely investigate the osteoblast‑ and osteoclast-associated mechanisms of the effect of CGRP administration on bone metabolism in primary osteoblasts. Primary osteoblasts were obtained from newborn rabbit calvaria and incubated with different concentrations of human CGRP (hCGRP), hCGRP and hCGRP (8‑37), or without treatment as a control. Intracellular calcium (Ca2+) and cyclic adenosine monophosphate (cAMP) were detected following treatment, as well as the expression levels of osteoblast differentiation markers, including activating transcription factor‑4 (ATF4) and osteocalcin (OC), and receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin (OPG). The isolated primary osteoblasts were found to stain positively for ALP. hCGRP treatment had no significant effect on transient intracellular Ca2+ in the osteoblasts. Treatment of the osteoblasts with hCGRP led to elevations in the expression levels of cAMP, ATF4 and OPG, and downregulation in the expression of RANKL, in a dose‑dependent manner. These effects were markedly reversed by the addition of hCGRP (8‑37). The results of the present study demonstrated that CGRP administration not only stimulated osteoblast differentiation, as demonstrated by upregulated expression levels of ATF4 and OC in the hCGRP‑treated osteoblasts, but also inhibited OPG/RANKL‑regulated osteoclastogenesis. CGRP may act as a modulator of bone metabolism through osteoblast and osteoclast-associated mechanisms, which result in osteoblast formation with subsequent activation of bone formation.

View Figures

View References

1	Offley SC, Guo TZ, Wei T, Clark JD, Vogel H, Lindsey DP, Jacobs CR, Yao W, Lane NE and Kingery WS: Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res. 20:257–267. 2005. View Article : Google Scholar : PubMed/NCBI
2	Irie K, Hara-Irie F, Ozawa H and Yajima T: Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech. 58:85–90. 2002. View Article : Google Scholar : PubMed/NCBI
3	Sample SJ, Heaton CM, Behan M, Bleedom JA, Racette MA, Hao Z and Muir P: Role of calcitonin gene-related peptide in functional adaptation of the skeleton. PLoS One. 9:e1139592014. View Article : Google Scholar : PubMed/NCBI
4	Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A and Guidobono F: Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol. 409:273–278. 2000. View Article : Google Scholar : PubMed/NCBI
5	Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA and Vignery A: Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice. J Bone Miner Res. 14:1067–1074. 1999. View Article : Google Scholar : PubMed/NCBI
6	Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP and Vignery A: Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone. 21:269–274. 1997. View Article : Google Scholar : PubMed/NCBI
7	Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB and Amling M: Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res. 19:2049–2056. 2004. View Article : Google Scholar : PubMed/NCBI
8	Villa I, Mrak E, Rubinacci A, Ravasi F and Guidobono F: CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. Am J Physiol Cell Physiol. 291:C529–C537. 2006. View Article : Google Scholar : PubMed/NCBI
9	Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F and Guidobono F: Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am J Physiol Endocrinol Metab. 284:E627–E633. 2003. View Article : Google Scholar : PubMed/NCBI
10	Naot D and Cornish J: The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone. 43:813–818. 2008. View Article : Google Scholar : PubMed/NCBI
11	Bo Y, Yan L, Gang Z, Tao L and Yinghui T: Effect of calcitonin gene-related peptide on osteoblast differentiation in an osteoblast and endothelial cell co-culture system. Cell Biol Int. 36:909–915. 2012. View Article : Google Scholar : PubMed/NCBI
12	Drissi H, Lieberherr M, Hott M, Marie PJ and Lasmoles F: Calcitonin gene-related peptide (CGRP) increases intracellular free Ca²⁺ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine. 11:200–207. 1999. View Article : Google Scholar : PubMed/NCBI
13	Matsuo K and Irie N: Osteoclast-osteoblast communication. Arch Biochem Biophys. 473:201–209. 2008. View Article : Google Scholar : PubMed/NCBI
14	Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165–176. 1998. View Article : Google Scholar : PubMed/NCBI
15	Yoo YM, Kwag JH, Kim KH and Kim CH: Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. Int J Mol Sci. 15:5874–5883. 2014. View Article : Google Scholar : PubMed/NCBI
16	Kauther MD, Xu J and Wedemeyer C: Alpha-calcitonin gene-related peptide can reverse the catabolic influence of UHMWPE particles on RANKL expression in primary human osteoblasts. Int J Biol Sci. 6:525–536. 2010. View Article : Google Scholar : PubMed/NCBI
17	Zhang Y, Sun X, Sun G, Liu S and Wang L: DNA damage induced by fluoride in rat osteoblasts. Fluoride. 39:191–194. 2006.
18	Li SH, Guo DZ, Li B, Yin HB, Li JK, Xiang JM and Deng GZ: The stimulatory effect of insulin-like growth factor-1 on the proliferation, differentiation and mineralisation of osteoblastic cells from Holstein cattle. Vet J. 179:430–436. 2009. View Article : Google Scholar
19	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
20	Yu HT, Yu M, Li CY, Zhan YQ, Xu WX, Li YH, Li W, Wang ZD, Ge CH and Yang XM: Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma. J Biol Chem. 284:13335–13347. 2009. View Article : Google Scholar : PubMed/NCBI
21	Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
22	Vignery A and McCarthy TL: The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone. 18:331–335. 1996. View Article : Google Scholar : PubMed/NCBI
23	Tian G, Zhang G and Tan YH: Calcitonin gene-related peptide stimulates BMP-2 expression and the differentiation of human osteoblast-like cells in vitro. Acta Pharmacol Sin. 34:1467–1474. 2013. View Article : Google Scholar : PubMed/NCBI
24	Kawase T, Howard GA, Roos BA and Burns DM: Diverse actions of calcitonin gene-related peptide on intracellular free Ca²⁺ concentrations in UMR 106 osteoblastic cells. Bone. 16(Suppl 4): S379–S384. 1995. View Article : Google Scholar
25	Bjurholm A, Kreicbergs A, Brodin E and Schultzberg M: Substance P- and CGRP-immunoreactive nerves in bone. Peptides. 9:165–171. 1988. View Article : Google Scholar : PubMed/NCBI
26	Tippins JR, Morris HR, Panico M, Etienne T, Bevis P, Girgis S, MacIntyre I, Azria M and Attinger M: The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP). Neuropeptides. 4:425–434. 1984. View Article : Google Scholar : PubMed/NCBI
27	Burns DM, Stehno-Bittel L and Kawase T: Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and-dependent mechanisms. Am J Physiol Cell Physiol. 287:C457–C467. 2004. View Article : Google Scholar : PubMed/NCBI
28	Katafuchi T, Kikumoto K, Hamano K, Kangawa K, Matsuo H and Minamino N: Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family its isolation from porcine brain, structure, tissue distribution and biological activity. J Biol Chem. 278:12046–12054. 2003. View Article : Google Scholar : PubMed/NCBI
29	Born W, Fischer JA and Muff R: Receptors for calcitonin gene-related peptide, adrenomedullin and amylin: The contributions of novel receptor-activity-modifying proteins. Receptors Channels. 8:201–209. 2002. View Article : Google Scholar
30	Lian N, Lin T, Liu W, Wang W, Li L, Sun S, Nyman JS and Yang X: Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem. 287:35975–35984. 2012. View Article : Google Scholar : PubMed/NCBI
31	Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, et al: ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry Syndrome. Cell. 117:387–398. 2004. View Article : Google Scholar : PubMed/NCBI
32	Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z, Cho SG, Li C, Yi T, Wu X, et al: Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development. 136:2747–2756. 2009. View Article : Google Scholar : PubMed/NCBI
33	Angelopoulos NG, Goula A, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D, Malaktari S, Athanasiou V and Tolis G: Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major. J Bone Miner Metab. 25:60–67. 2007. View Article : Google Scholar
34	Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR and Kingery WS: Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption. Bone. 46:1369–1379. 2010. View Article : Google Scholar :